Research & development has been the foundation of Boehringer Ingelheim's success and continues to be the major driver of innovative, new medicines for the treatment of diseases with an unmet therapeutic need.
Our constant quest for innovation is not limited to our own discoveries but includes successful ongoing collaborations. We actively pursue new collaborations with external partners, ranging from academic institutions to biopharmaceutical enterprises and start-up companies.